Bioactivity:

Cetuximab anti-EGFR) a novel molecular-targeted agentis an inhibitor of EGFR monoclonal humanized antibody interacting with the extracellular binding site of EGFR to block ligand stimulation

CAS nr:

205923-56-4

Purity:

98%

Molecular Weight:

145000

SMILES:

Formula:

Pathway:

Tyrosine Kinase/Adaptors,Angiogenesis,JAK/STAT signaling

Target:

EGFR,EGFR,EGFR